Our call to leverage big data to accelerate blood cancer research.

Big Data has proven to offer new insights that can contribute to advances in novel therapies and more efficient medicines.

We urge researchers across the globe to break data silos and embrace cooperation to foster blood cancer research. It takes one missing piece of data to eureka.

Data is knowledge. Access to data gives scientists and healthcare professionals insights into disease characteristics and correlations between different biomarkers. Today, artificial intelligence algorithms are already reimaging research in many disciplines of life sciences and medicine, and could help us harness the full power of data. Thankfully, one barrier stands in the way: data silos. However, this can be easily overcome if we start to cooperate closer and share data within a secure and trusted ecosystem.

Read our latest 'Manifesto' to learn more about our call to all stakeholders in healthcare and life sciences.

Working in such an outstanding team, we have managed to collect a very large amount of data sets from all over Europe. And more are on the way! The innovative HARMONY Big Data Platform, a central analytical infrastructure, was launched in 2017 to harmonize the data sets donated by European hospitals, academic institutions conducting clinical trials, and pharmaceutical companies, among other data custodians. Today, the HARMONY data lake is one of the largest databases of its kind, and still growing: the Alliance has already identified over 150,000 cases not only from Europe, but from all around the world. In addition, careful procedures have been installed to ensure the anonymization and the quality of the data. HARMONY data scientists have developed sophisticated methods for data harmonization and analysis. This moonshot continues, and you can be a part of it!

Click here to open our 'Manifesto' folder >

Reuse your data;
Collaborate with us within trusted networks;
Help us unlock knowledge for social good.

The HARMONY Alliance teams have been working hard to collect data and speed up research on Hematologic Malignancies for the past six years. Over 120+ organizations from 28 European countries already share the HARMONY Alliance mission: personalized treatment for blood cancer patients.

Check our Data Barometer >
View our Research Projects >
Read more about our Big Data Platform >
Read our press release about becoming a non-profit research foundation >

Become Involved!

What can we offer you?

Co-operative working groups, hospitals and academic institutions are invited to collaborate and contribute data to the HARMONY Alliance Big Data Platform. By becoming an Associated Member of HARMONY you will not only contribute to mproving outcomes for individuals with blood cancer, you can:

submit research proposals;
become part of a dedicated research group that includes skilled data scientists;
contribute to scientific publications under the umbrella of the HARMON Alliance;
be compensated for your efforts in sharing your data.

Click here to learn more about the steps to take >

Receive the latest news. Click here to subscribe!

Public-private partnership for Big Data in Hematology

HARMONY and HARMONY PLUS are funded through the Innovative Medicines Initiative (IMI), Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients. Funding is received from the IMI 2 Joint Undertaking and is listed under grant agreement for HARMONY No. 116026 and grant agreement for HARMONY PLUS No. 945406. This Joint Undertaking receives support from the European Union’s Horizon 2020 Research and Innovation Programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA).